Primary Sjögren syndrome with tumefactive central nervous system involvement

American Journal of Neuroradiology

Volumn 29, Issue 10, 2008, Pages 1878-1879

  Sanahuja, Jordi ^a   Ordonez Palau S ^a   Begue R ^a   Brieva, L ^a   Boquet, D ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; LA ANTIBODY; PREDNISONE; RO ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SALIVARY GLAND SCINTISCANNING; SCHIRMER TEST; SJOEGREN SYNDROME;

BRAIN DISEASES; FEMALE; GRANULOMA, PLASMA CELL; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 56849101528     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1204     Document Type: Article

References (15)

1. Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002;81:270-80
2. Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjögren syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum 2004;34:623-30
3. Soliotis FC, Mavragani CP, Moutsopoulos HM. Central nervous system involvement in Sjögren's syndrome. Ann Rheum Dis 2004;63:616-20
4. de Seze J, Delalande S, Vermersch P. Neurological manifestations in Sjogren syndrome. Rev Med Interne 2005;26:624-36
5. Vitali C, Bombardieri S, Jonsson R, et al, for the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-58
6. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-91
7. Rosenbaum R, Barkhuizen A. Primary Sjögren's syndrome. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice. 2nd ed. London, UK: Informa Healthcare; 2006:1587-91
8. Comi G. Multiple sclerosis: pseudotumoral forms. Neurol Sci 2004;25:S374-79
9. Khoshyomn S, Braff SP, Penar PL. Tumefactive multiple sclerosis plaque. J Neurol Neurosurg Psychiatry 2002;73:85
10. Selkirk SM, Shi J. Relapsing-remitting tumefactive multiple sclerosis. Mult Scler 2005;11:731-34
11. Bakchine S, Duyckaerts C, Hassine L, et al. Lesions neurologiques centrals et peripheriques au cours d'un syndrome de Gougerot-Sjogren primitif. Rev Neurol 1991;147:368-75
12. Okubo H, Maekawa H, Ogawa K, et al. Pseudolymphoma of the liver associated with Sjögren's syndrome. Scand J Rheumatol 2001;30:117-19
13. Cacoub P, Ginsburg C, Tazi Z, et al. Sjögren's syndrome with acute renal failure caused by renal pseudolymphoma. Am J Kidney Dis 1996;28:762-66
14. Eckstein RP, Hollings RM, Martin PA, et al. Pancreatic pseudotumor arising in association with Sjögren's syndrome. Pathology 1995;27:284-88
15. Chang Y, Horoupian DS, Lane B, et al. Inflammatory pseudotumor of the choroid plexus in Sjögren's disease. Neurosurgery 1991;29:287-90